ArticleESMO gastrointestinal oncology2024
Integration of genomic aberrations to predict clinical outcomes for patients with gastroesophageal adenocarcinoma receiving neoadjuvant chemotherapy.
E C Smyth et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.